ANI Pharmaceuticals
ANIP
#5234
Rank
HK$13.31 B
Marketcap
HK$579.83
Share price
2.65%
Change (1 day)
-17.92%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2026 (TTM): HK$37.73

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$37.90. In 2025 the company made an earnings per share (EPS) of HK$27.47 an increase over its 2024 EPS that were of -HK$8.79.

EPS history for ANI Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$37.7337.36%
2025HK$27.47-412.5%
2024-HK$8.79
2022-HK$23.86-6.46%
2021-HK$25.5072.87%
2020-HK$14.75-476%
2019HK$3.92-62.12%
2018HK$10.36
2015HK$10.52-47.66%
2014HK$20.09-142.11%
2013-HK$47.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$52.26 37.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96-84.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
HK$56.97 50.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
HK$119.67 215.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
-HK$19.77-152.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.14-190.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.94-86.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
HK$14.72-61.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-HK$198.38-623.40%๐Ÿ‡บ๐Ÿ‡ธ USA